Voortzetting Follow-Up Imaging Onderzoek bij Glaucoom en Oculaire Hypertensie.

Follow-up of glaucoma and ocular hypertension patients with improved imaging techniques.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20750

Enrollment

685

Registered

2008-01-10

Start date

2000-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Glaucoma

Interventions

Glaucoma group: careful follow-up with visual fields and structural imaging

no experimental intervention (care as usual). Ocular hypertension groups: 3 arms (timolol, betaxolol and placebo eye drops), masked, randomized, prospective, placebo-controlled

careful follow-up with visual fields and structural imaging.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed consent; 2. Glaucoma; 3. Ocular hypertension.

Exclusion criteria

Exclusion criteria: 1. Ocular opacifications (eg. of the cornea, lens etc.); 2. Nystagmus; 3. Significant other eye disorders (eg. age-related macular degeneration, other than mild cataract); 4. Systemic disease possibly affecting the eye (eg. systemic hypertension, diabetes); 5. Refractive errors larger than 10 D myopia or 5 D hyperopia.

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of glaucoma diagnostics (i.e. for glaucoma detection and for glaucoma progression detection).	—

Contacts

Public ContactH.G. Lemij

Oogziekenhuis Rotterdam, Schiedamsevest 180

Lemij@oogziekenhuis.nl+31 (0)10 4017777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)